Benitec Biopharma Inc.
BNTC· Nasdaq
BNTCBenitec Biopharma Inc.
Filed Sep 22, 2025 · 10-K · 84 days after period end · 0001193125-25-211361
| Metric | Q4 2025 | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures |
|---|---|---|---|---|
| Revenue | — | $0.00 | $7.00K | $0.00 |
| Net Income | -$8.81M | -$4.72M | -$4.66M | -$5.07M |
| EPS Diluted | -$0.21 | — |
Benitec Biopharma Inc. · CIK 1808898 · Engraved from SEC EDGAR
| — |
| — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Jun 30, 2025 · filed Sep 22, 2025 · 84 d after period end
